CRISPR Therapeutics AG
NASDAQ:CRSP
CRISPR Therapeutics AG
NASDAQ:CRSP
Price:
51.84
USD
-8.97%
Market Closed
Market Cap:
$5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
CH |
|
Hoya Corp
TSE:7741
|
JP |
|
Suzuki Motor Corp
TSE:7269
|
JP |
|
U
|
Uniqa Insurance Group AG
VSE:UQA
|
AT |
|
L
|
LH Shopping Centers Leasehold Real Estate Investment Trust
SET:LHSC
|
TH |
|
N
|
Newcrest Mining Ltd
TSX:NCM
|
AU |
Wall St Price Targets
CRSP Price Targets Summary
CRISPR Therapeutics AG
CRISPR Therapeutics AG
Wall Street analysts forecast CRSP stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CRSP is 81.92 USD with a low forecast of 33.33 USD and a high forecast of 305.55 USD.
Lowest Forecast
Price Target
33.33
USD
36% Downside
Average Forecast
Price Target
81.92
USD
58% Upside
Highest Forecast
Price Target
305.55
USD
489% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRSP's stock price target?
Price Target
81.92
USD
81.92
USD
According to Wall Street analysts, the average 1-year price target for CRSP is 81.92 USD with a low forecast of 33.33 USD and a high forecast of 305.55 USD.
What is the Revenue forecast for CRISPR Therapeutics AG?
Projected CAGR
119%
119%
Over the last 10 years, the compound annual growth rate for Revenue has been 33%. The projected CAGR for the next 8 years is 119%.
